Table 2 Indications for pharmacologic stress echo
From: Assessment of dipyridamole stress echocardiography for risk stratification of diabetic patients
Indications | 483 -N(%) | 264 - N(%) |
|---|---|---|
Routine clinical and imaging follow-up | 123 (25 %) | 72 (27 %) |
Thoracic pain | 107 (22 %) | 58 (22 %) |
Perioperative risk stratification | 76 (15 %) | 41 (15 %) |
Evaluation of known coronary artery disease | 69 (14 %) | 37 (14 %) |
Altered resting EKG | 30 (6 %) | 19 (7 %) |
Dyspnea/fatigue | 18 (4 %) | 12 (4 %) |
Altered/insufficient exercise stress testing (N/%) | 132 (27 %) | 70 (26 %) |